# Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Study · id `cardio:ct-nct04023227` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04023227](<https://clinicaltrials.gov/study/NCT04023227>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04023227

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 922 participants.

## Technical summary

Registry record NCT04023227. Randomized; single masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2025-03-16 (actual). Results posted on 2026-05-11.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 922 participants (enrolled count; ClinicalTrials.gov record NCT04023227, source copy `cardio:ctgov-nct04023227-2026-05-11`, retrieved 2026-10-26)
- Started: 2019-12-10 (actual) (ClinicalTrials.gov record NCT04023227, source copy `cardio:ctgov-nct04023227-2026-05-11`, retrieved 2026-10-26)
- Primary completion: 2025-03-16 (actual) (ClinicalTrials.gov record NCT04023227, source copy `cardio:ctgov-nct04023227-2026-05-11`, retrieved 2026-10-26)
- Completion: 2025-03-31 (actual) (ClinicalTrials.gov record NCT04023227, source copy `cardio:ctgov-nct04023227-2026-05-11`, retrieved 2026-10-26)
- Results first posted: 2026-05-11 (ClinicalTrials.gov record NCT04023227, source copy `cardio:ctgov-nct04023227-2026-05-11`, retrieved 2026-10-26)
- Countries: Argentina; Brazil; Colombia; Mexico (ClinicalTrials.gov record NCT04023227, source copy `cardio:ctgov-nct04023227-2026-05-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04023227-2026-05-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC
- Acronym: PARACHUTE-HF
- Condition: Chagas Disease
- Condition: Heart Failure
- Intervention (Drug): Sacubitril/valsartan
- Intervention (Drug): Enalapril
- Lead sponsor: Novartis Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: Enalapril (`cardio:enalapril`)
- Registry lists this organization as the lead sponsor: Novartis (`cardio:novartis`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: An Open-Label, Multicenter Randomized Clinical Trial (`cardio:pubmed-41335448`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c3a3515b8e54bd61efbc7d3c96246ebae3140b25589406b2c75a6239a2f631a6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
